BD Develops Self-Injection Delivery System for Biologic Therapies

Advances in large-molecule biologic treatments—and the emerging shift of care from hospitals and clinics to the home—are two of the factors influencing the ever-evolving healthcare market. To address these issues, BD Medical, a segment of BD (Becton, Dickinson and Company) is developing the BD Microinfusor patch injector.
Healthcare Packaging